PALO ALTO, Calif.--Incyte Pharmaceuticals here has signed a multiyear database partnership agreement with Organon, a pharmaceutical business unit of Akzo Nobel. The deal will give Organon access to Incyte's LifeSeq gene sequence and expression database and its LifeSeq GeneAlbum reagent set in exchange for annual access fees. Organon will be responsible for developing and commercializing any drugs that arise from the collaboration, but Incyte could receive royalties on sales developed with its technology and databases.